Drugs / Budesonide/formoterol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01593826 | May → Oct 2012 | asthma | Orion Corporation, Orion Pharma | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Budesonide/formoterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01593826 ↗ |
| Known as | Budesonide/formoterol Easyhaler | “The purpose of this study is to compare the test product Budesonide/formoterol Easyhaler with the marketed product Symbicort Turbuhaler in terms of the drug absorbed into the...” NCT01593826 ↗ |
| Route | Inhaled | “2 inhalations as a single dose” NCT01593826 ↗ |